Analysis of HER2-positive breast cancer datasets reveals a positive correlation between HSF1 and components of the HSP chaperone complex, including HSP90 and HSP70, with simultaneous overexpression linked to poorer clinical outcomes. Here, ERBB2 is linked to breast cancer.